Shots: KaliVir to receive $56M as upfront & other payments supporting the research & preclinical activities of VET2-L2 & is eligible to receive $307M & $271M as development, regulatory & commercialization for VET2-L2 & second product, respectively along with royalties on sales of each licensed… Read More »Astellas Collaborates with KaliVir to Develop and Commercialize VET2-L2
At TEDMED’s gathering in Boston, we had the opportunity to interview on stage the world’s top virologist, Peter Piot. In plain English, Peter provided solid scientific knowledge about COVID-19 and how to cope with it. Short answers, clear explanations. Based on that live interview here… Read More »
The post Inside quarantine: from SARS in Toronto to coronavirus in Wuhan appeared first on Healthy Debate.